About us


Health care systems are posed with the challenge to provide all citizens with health services that are both of high quality and financially affordable. Rapid advances in medical technology, for example in personalized medicine, and substantial changes in demography increase the problems of balancing the quality and the cost of medical care. Thorough evaluation of effectiveness and cost-effectiveness on novel health care approaches is a key precondition to rational decision-making, and thus supports translation of innovation, up to everyday health care.

The objective of the Institute of Health Economics and Health Care Management (IGM) is to contribute to improving the effectiveness and efficiency of health care. The empirical basis is provided by cohort studies, registries, but also claims data by health insurers, and by clinical studies. The Institute's research topics include:

Quantitative Methods in Health Economics

  • Analysing health consequences of life course specific events
  • Applicating insights from the field of behavioural economic on health-related questions
  • Applicating and developing quantitative health-economic methods
  • Analysing regional and social inequality

Economics and Management of Diabetes

  • Economic evaluations of strategies for prevention and treatment of diabetes
  • Analysis of the economic impact of metabolic diseases, including obesity, type 2 diabetes, type 1 diabetes and diabetic complications
  • Identification of drivers and consequences for health behavior and patient self-management

Health Care Management

  • Development of methods to measure patient-based costs and Patient-Reported Outcome
  • Economic evaluation of stratified strategies of patient management
  • Identification of risk groups with regard to Patient-Reported Outcome and development of targeted, outcome-oriented health care strategies

Former: Economics and Management of Lung Diseases

  • Analysing health care for individuals with chronic lung diseases in a longitudinal perspective
  • Describing the economic impact of distinct chronic lung diseases
  • Evaluating patient reported outcomes in context of distinct disease management approaches